enVVeno Medical Corporation Warrants (NVNOW)
$0.01
$0.00
(-32.98%)
As on 26-May-2023 15:30EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
8 Years Aggregate
CFO
$-56.70 Mln
EBITDA
$-74.92 Mln
Net Profit
$-83.53 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
enVVeno Medical Corporation Warrants (NVNOW)
| -88.5 | -85.3 | -91.0 | -96.4 | -60.2 | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout enVVeno Medical Corporation Warrants (NVNOW)
enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a... surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Read more
-
CEO & Director
Mr. Robert A. Berman
-
CEO & Director
Mr. Robert A. Berman
-
Headquarters
Irvine, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for enVVeno Medical Corporation Warrants (NVNOW)
What is the current share price of enVVeno Medical Corporation Warrants (NVNOW) Today?
The share price of enVVeno Medical Corporation Warrants (NVNOW) is $0.01 (NASDAQ) as of 26-May-2023 15:30 EDT. enVVeno Medical Corporation Warrants (NVNOW) has given a return of -60.21% in the last 3 years.
What is the current PB & PE ratio of enVVeno Medical Corporation Warrants (NVNOW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-0.03 |
0.02 |
2021 |
-0.16 |
0.05 |
2020 |
-0.31 |
0.39 |
2019 |
-0.11 |
0.88 |
2018 |
-0.29 |
1.88 |
What is the 52 Week High and Low of enVVeno Medical Corporation Warrants (NVNOW)?
The 52-week high and low of enVVeno Medical Corporation Warrants (NVNOW) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of enVVeno Medical Corporation Warrants (NVNOW)?
enVVeno Medical Corporation Warrants (NVNOW) has a market capitalisation of -- as on 26-May-2023. As per SEBI classification, it is a company.
Should I invest in enVVeno Medical Corporation Warrants (NVNOW)?
Before investing in enVVeno Medical Corporation Warrants (NVNOW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.